Advancements in digital cell morphology technology has enabled high-resolution digital imaging of blood cells which help in early disease detection. Point-of-care hematology analyzers are compact desktop analyzers used in physician office laboratories, blood banks and hospitals to provide quick CBC results. The Global Hematology Analyzer Market is estimated to be valued at US$ 4.94 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Hematology Analyzer Market Trends are Boule Diagnostics AB, Bio-Rad Laboratories, Danaher Corporation, Sysmex, Horiba Medical, Nihon Kohden Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Drew Scientific, Diatron, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Cormay Diagnostics, AGD Biomedicals, Pioneer Impex, BIOGENIX INC. PVT. LTD, and Drucker Diagnostics. Growing geriatric population and increasing prevalence of blood disorders is driving the demand for hematology analyzers globally. Leading players are expanding their product portfolio and geographical presence through partnerships and mergers & acquisitions to consolidate their position in the dynamic hematology analyzers market.

Market Drivers

The primary driver augmenting the hematology analyzers market growth is increasing incidences of blood disorders worldwide. According to the World Health Organization (WHO), around 1.62 billion people globally are affected by anemia, mostly women and children. Rising cases of sickle cell disease, hemophilia, and blood cancer like leukemia are propelling the demand for advanced hematology testing and driving the adoption of desktop and semi-automated analyzers in diagnostic labs and hospitals. Additionally, growing awareness about blood-related conditions and rising healthcare expenditure in developing nations is supporting the market expansion over the forecast timeline.

Gets More Insights on: Hematology Analyzer Market